Advertisement

The Academic-Corporate Merger in Medicine

A Two-Edged Sword
  • Arnold S. Relman

Abstract

The rapid development of molecular genetic technology in the past decade has opened up exciting new vistas for the application of this technology to the manufacture of important biological molecules, as well as to the diagnosis and treatment of inherited diseases. The enthusiasm attending this development in the research laboratories of universities and medical schools generated an equal stir in the corporate world, where the possibilities for commercial exploitation of these dramatic scientific advances were immediately appreciated.

Keywords

Faculty Member Academic Institution Senior Faculty Business Corporation Corporate Contribution 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Aubrey Milunsky and George J. Annas 1985

Authors and Affiliations

  • Arnold S. Relman
    • 1
    • 2
  1. 1.New England Journal of MedicineBostonUSA
  2. 2.Harvard Medical SchoolBostonUSA

Personalised recommendations